With Maybank IB Research’s latest call upgrade, a total of 13 out of 18 analysts recommended a “buy” on KPJ, according to Bloomberg data.
PETALING JAYA: Maybank IB Research is the second research house over the last five months to upgrade its recommendation on KPJ Healthcare Bhd
to “buy”, as it believes the stock’s selling is overdone and new value is expected to emerge.
The research house has forecast KPJ to record stronger results in the third quarter of financial year 2019 (3Q19), exceeding the RM43.4mil core net profit registered in 2Q19.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
